Atypical exocrine and endocrine pancreatic tumors (anaplastic, small cell, and giant cell types): CT and pathologic features in 14 patients

被引:43
|
作者
Ichikawa, T
Federle, MP
Ohba, S
Ohtomo, K
Sugiyama, A
Fujimoto, H
Haradome, H
Araki, T
机构
[1] Univ Pittsburgh, Presbyterian Hosp, Med Ctr, Dept Radiol, Pittsburgh, PA 15213 USA
[2] Nagoya City Univ, Sch Med, Dept Radiol, Nagoya, Aichi, Japan
[3] Univ Tokyo, Sch Med, Dept Radiol, Tokyo, Japan
[4] Natl Tosei Hosp, Dept Radiol, Shizuoka, Japan
[5] Numazu City Hosp, Dept Radiol, Numazu, Japan
[6] Kyorin Univ, Sch Med, Dept Radiol, Mitaka, Tokyo, Japan
来源
ABDOMINAL IMAGING | 2000年 / 25卷 / 04期
关键词
exocrine pancreatic tumor; endocrine pancreatic tumor;
D O I
10.1007/s002610000058
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Our purpose was to review a series of 14 patients with atypical exocrine and endocrine pancreatic tumors to derive characteristic computed tomographic and pathologic features that might allow better diagnosis, categorization, and management of these patients. Methods: Medical records from several university medical centers were reviewed retrospectively. Results: We identified three separate types of pancreatic tumors that had substantially different morphologic and prognostic features. Among these rare tumors, anaplastic carcinoma was the most common (nine of 14 cases), and these tumors were large, partly necrotic, locally invasive, and invariably metastatic (lymph nodes and/or liver) at the time of diagnosis. Three patients with poorly differ entiated (small cell) carcinoma had a confluent pancreatic mass and lymphadenopathy but no ductal obstruction, closely resembling lymphoma or metastatic disease. Two patients with giant cell (osteoclastlike) carcinoma had a large, encapsulated multicystic tumor with hemorrhage, and these tumors were resectable for cure. Conclusion: Although a specific diagnosis may not be possible in some cases, we believe that knowledge of certain pathologic and computed tomographic features should lead to optimal diagnosis, therapy, and prognosis.
引用
收藏
页码:409 / 419
页数:11
相关论文
共 50 条
  • [31] Complete Pathologic Response in Lung Tumors in Two Patients with Metastatic Non-small Cell Lung Cancer Treated with Erlotinib
    Weber, Britta
    Sorensen, Boe S.
    Knap, Marianne Marquard
    Madsen, Hans Henrik
    Nexo, Ebba
    Meldgaard, Peter
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : 1946 - 1949
  • [32] Discordance between clinical and pathologic staging and the timeliness of care of non-small cell lung cancer patients diagnosed with operable tumors
    Taylor, Oliver
    Boardman, Glenn
    Bentel, Jacqueline
    Laycock, Andrew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (06) : 706 - 714
  • [33] CT-Based Radiomic Biomarker Features Predict Prognosis in Patients with Limited Stage Small Cell Lung Cancer
    Kamran, S. C.
    Coroller, T. P.
    Milani, N.
    Agrawal, V.
    Franco, I.
    Chopra, N.
    Zeleznik, R.
    Aerts, H.
    Mak, R. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S12 - S13
  • [34] Comparison of tumor textural features in PET and CT images in non-small cell lung cancer (NSCLC) patients
    Orlhac, Fanny
    Soussan, Michael
    Eder, Veronique
    Buvat, Irene
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [35] Radiomic Features on Baseline CT Are Predictive of Recurrence in Early Stage Non-Small Cell Lung Cancer Patients
    Vaidya, P.
    Patil, P.
    Choi, H.
    Velcheti, V.
    Madabhushi, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2393 - S2393
  • [36] CLINICAL AND MORPHOLOGICAL FEATURES OF NON-SMALL CELL LUNG CANCER IN PATIENTS WITH DIFFERENT TYPES OF HISTOLOGICAL CHANGES TO THE BRONCHIAL EPITHELIUM
    Zavyalov, M., V
    Loos, D. M.
    Pismenny, D. S.
    Durov, A. A.
    Pankova, O., V
    Rodiono, E. O.
    Tuzikov, S. A.
    Tashireva, L. A.
    Perelmuter, V. M.
    BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY, 2022, (03): : 67 - 74
  • [37] Frequency of anaplastic lymphoma kinase (ALK) positive tumors among African American non-small cell lung cancer (NSCLC) patients.
    Gadgeel, Shirish M.
    Cote, Michele L.
    Bepler, Gerold
    Murphy, Valerie
    Malysa, Agnes
    Wozniak, Antoinette J.
    Sukari, Ammar
    Schwartz, Ann G.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] Osteoclastic and pleomorphic giant cell tumors of the pancreas diagnosed via EUS-guided FNA: unique clinical, endoscopic, and pathologic findings in a series of 5 patients
    Moore, Jill C.
    Hilden, Kristen
    Bentz, Joel S.
    Pearson, Randall K.
    Adler, Douglas G.
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (01) : 162 - 166
  • [39] CT and PET radiomic features associated with major pathologic response to neoadjuvant immunotherapy in early-stage non-small cell lung cancer (NSCLC).
    Nakajima, Erica C.
    Leal, Jeffrey P.
    Fu, Wei
    Wang, Hao
    Chaft, Jamie E.
    Hellmann, Matthew David
    Pomper, Martin
    Forde, Patrick M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence
    Choe, Jooae
    Kim, Mi Young
    Yun, Jae Kwang
    Lee, Geun Dong
    Kim, Yong-Hee
    Choi, Sehoon
    Kim, Dong Kwan
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2021, 217 (04) : 871 - 881